Remedium Capital Partners, LLC

Q3 2026 13F-HR Holdings

Location
West Palm Beach, FL
Holdings as of
9/30/2026
Date filed
11/13/2026
Form type
13F-HR
Num holdings
6
Total value ($000)
$273,591
Net value change ($000)
-178,036 (-39.4%)
New positions
2
Sold out positions
2
Turnover %
69.9%
Sector allocation + QoQ delta (equities-only)
Prev filing: 8/7/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Damora Therapeutics Inc 43,528 NEW
Korsana Biosciences Inc 16,592 NEW
Top Reduces (Value $000, Stocks/ETFs)
APGE -77,871 -100.0%
ORKA -69,533 -46.7%
GLTO -53,203 -100.0%
SYRE -26,659 -20.5%
JBIO -9,658 -27.5%
CBIO -1,232 -18.9%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type